Stem cell therapy for cerebral palsy in Istanbul typically costs from $14,500 to $14,500, depending on the number of sessions and clinical protocols. Patients save around 60% compared to the US, where this procedure costs $50,000 on average. Most Istanbul packages include GMP-standard cell preparation, pediatric consultations, VIP airport transfers, and several nights of hospitalization.
Bookimed Expert Insight: Istanbul serves as Turkey's primary center for neuroregenerative research, surpassing even Ankara in specialty depth. The city's advantage lies in its high-volume GMP laboratories, such as the one led by Prof. Erdal Karaöz at Liv Hospital Ulus. This facility was Turkey's first private GMP-standard lab. These centers offer institutional R&D expertise that individual clinics rarely match, providing access to Ministry-approved clinical trials for pediatric neurology.
Choosing a JCI-accredited facility like Medical Park Göztepe or NP Istanbul Brain Hospital ensures the treatment happens within an established multidisciplinary environment. This is vital when coordinating care between neurologists, pediatricians, and stem cell scientists.
| Turcja | Austria | Hiszpania | |
| Terapia komórkami macierzystymi przy MPD | od $15,000 | od $20,000 | od $25,000 |
Day 1
Day 2
Day 3
Day 4
Day 5
Week 1-2
Week 3-4
Week 5-6
Please note that every patient"s case is unique, and the timeline may vary depending on the individual"s response to the treatment.
Dr Topcular specjalizuje się w terapii komórkami macierzystymi w przypadku porażenia mózgowego, posiadając wiedzę neurologiczną zdobytą na Uniwersytecie Stambulskim Cerrahpaşa.
Dr. Merve Cemil graduated with honors from the Istanbul University-Cerrahpaşa Faculty of Medicine. She specializes in Physical Medicine and Rehabilitation at Central Hospital in Istanbul. Dr. Cemil treats complex neurological and orthopedic conditions using ultrasound-guided injection techniques.
Dr Gunaydin specjalizuje się w chirurgii dziecięcej, w tym w minimalnie inwazyjnych zabiegach dla dzieci.
Prof. Karaöz był pionierem pierwszego w Turcji instytucjonalnego centrum badań nad komórkami macierzystymi i prowadzi badania kliniczne w zakresie porażenia mózgowego od 2000 roku.